Clinical trial
Valproate in Dementia (VALID)
NCT00071721 · Alzheimer's Disease Cooperative Study (ADCS), Other · Completed
Key facts
| NCT number | NCT00071721 |
|---|---|
| Title | Valproate in Dementia (VALID) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial of Valproate to Attenuate the Progression of Alzheimer's Disease (AD) |
| Lead sponsor | Alzheimer's Disease Cooperative Study (ADCS), Other |
| Collaborators | National Institute on Aging (NIA) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | Valproate, Placebo |
| Enrollment | 313 |
| Start date | Oct 1, 2003 |
| Primary completion | Feb 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Oct 31, 2003 |
| Last update posted | Sep 25, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: